Skip to main content
Main navigation
Home
About pCPA
Who We Are
Governance
FAQs
Negotiations
Recent Updates
Forms and Publications
Brand Name Drugs
Negotiations Status
Negotiation Process
Generic Drugs
Biologics/Biosimilars
Contact Us
EN
FR
Vimizim (elosulfase alfa)
pCPA File Number:
20945
Negotiation Status:
Concluded with an LOI
Indication(s):
Mucopolysaccharidosis IVA (Morquio A syndrome)
Sponsor/Manufacturer:
BioMarin Pharmaceutical Inc.
CADTH Project Number:
SR0456-000
pCPA Engagement Letter Issued:
2016-10-28
Negotiation Process Concluded:
2018-11-29